Results from HPS2-THRIVE study of TREDAPTIVE™ presented at American College of Cardiology Scientific Sessions
Results from the HPS2-THRIVE study...
9 March 2013 | By Merck
Results from the HPS2-THRIVE study...
List view / Grid view
Results from the HPS2-THRIVE study...
9 March 2013 | By Merck
Results from the HPS2-THRIVE study...
The FDA has approved an updated label for VYTORIN® (ezetimibe/simvastatin)...
25 January 2012 | By Merck
The FDA has approved an updated label for VYTORIN® (ezetimibe/simvastatin)...
Merck and Astellas US LLC have entered into an agreement...
26 July 2011 | By Merck
Merck and Astellas US LLC have entered into an agreement...